Feasibility of Pulmonary Resection for Lung Cancer in Patients With Coronary Artery Disease or Atrial Fibrillation

Kitamura, Yoshitaka; Suzuki, Kenji; Teramukai, Satoshi; Sonobe, Makoto; Toyooka, Shinichi; Nakagawa, Yoshihisa; Yokomise, Hiroyasu; Date, Hiroshi; Arikura, Jun; Miyajima, Masayoshi; Tsunooka, Nobuo; Ueda, Sou; Shiono, Satoshi; Ichimura, Hajime; Ohtaki, Yohichiroh; Kawashima, Osamu; Takahashi, Naoki; Iwata, Teruo; Murakawa, Tomokazu; Shimada, Yasushi; Horio, H; Ishibashi, Hiroyuki; Kawachi, Riken; Omori, Taku; Nio, Masaki; Hashimoto, Takuya; Waseda, Ryuichi; Tsunezuka, Yoshio; Tanaka, Noriko; Eguchi, Takashi; Agatsuma, Hiroyuki; Mizuno, Yoshimasa; Nishikawa, Shigeto; Isaka, Mahito; Haneda, Hiroshi; Narita, Kenichi; Okuda, Kentaro; Kobayashi, Yohei; Terada, Yukiko; Takemoto, Toshiki; Nakajima, Rintaro; Kanzaki, Ryu; Okami, Jiro; Kadota, Yoshihisa; Hanaoka, Nobuharu; Hayashi, Akira; Nishio, Wataru; Takahashi, Yūji; Nakamura, Hajime; Taniguchi, Yoshinori; Yamashina, Akira; Yamamoto, Hiroshi; Miyata, Yoko; Matsuura, Minoru; Tanaka, Toshikazu; Matsuura, Natsumi; Suehisa, Hiroshi; Chang, Shih Sheng; So, Tetsuya; Osaki, Tsukasa; Takeo, Sadanori; Takenoyama, Mitsuhiro; Miyazaki, Toru; Marutsuka, Takashi; Yoshimoto, Kentaro; Kariatsumari, Kota; Yanagi, Masakazu

doi:10.1016/j.athoracsur.2016.08.077

Cited by 6 publications

(4 citation statements)

References 26 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In European populations, the cumulative incidence of stent thrombosis for sirolimus-eluting stents and paclitaxel-eluting stents was 1.7% at 1 year and incidence continued to increase by 0.6% per year [28]. A recent report from Japan found that the incidence of stent thrombosis after lung resection was only 0.2% among patients with coronary stents, even though antiplatelet therapy had been discontinued in most patients [29]. Perioperative management of patients with coronary stents may differ for Japanese and American/European populations.…”

Section: Resultsmentioning

confidence: 99%

“…Thus, this analysis cannot conclusively determine whether perioperative temporary aspirin cessation is optimal for patients in high-risk groups. A recent report from Japan suggested that discontinuation of antiplatelet therapy may not increase postoperative complications in patients with coronary artery disease who underwent pulmonary resection [29]. In that study of 902 patients who had received preoperative diagnoses of coronary artery stenosis, 532 patients (59%) had coronary stents and 204 patients (23%) were treated with DES.…”

Section: Resultsmentioning

confidence: 99%

See 1 more Smart Citation

Recommendations for perioperative management of lung cancer patients with comorbidities

Tsubochi

Shibano

Endo

2017

Gen Thorac Cardiovasc Surg

View full text Add to dashboard Cite

ObjectivesTo improve surgical outcomes, clinicians must provide optimal perioperative care for comorbidities identified as significant factors in risk models for patients undergoing lung cancer surgery.MethodsWe reviewed trends in perioperative care for idiopathic pulmonary fibrosis, cardiovascular diseases, and end-stage renal diseases in patients undergoing lung cancer surgery, as large clinical databases indicate that these comorbidities are significant risk factors for lung cancer surgery. Articles identified by keyword searches were included in the analysis.ResultsSignificant predictive factors for acute exacerbation of idiopathic pulmonary fibrosis were identified. However, no effective perioperative care was identified for prevention of acute exacerbation of interstitial pneumonia. The timing of coronary revascularization and antithrombotic management for cardiovascular diseases are subjects of ongoing research, and acid–base balance is essential in the management of hemodialysis patients with end-stage renal diseases.ConclusionsTo improve surgical outcomes for lung cancer patients, future studies should continue to study optimal perioperative management of comorbidities.

show abstract

Section: Resultsmentioning

confidence: 99%

Section: Resultsmentioning

confidence: 99%

Recommendations for perioperative management of lung cancer patients with comorbidities

Tsubochi

Shibano

Endo

2017

Gen Thorac Cardiovasc Surg

View full text Add to dashboard Cite

show abstract

“…Level of evidence: Fair Strength of recommendation: A Major cardiac adverse events, particularly supraventricular arrhythmias, are among the most common complications in patients undergoing thoracic surgery (Cagirici et al 2005). Such events may occur after both lung resection (Kitamura et al 2017) and less invasive procedures such as video-assisted thorascopic lobectomy (Sandri et al 2017). Atrial fibrillation following pulmonary surgery can lead to hemodynamic instability and longer ICU and hospital stay (Frendl et al 2014).…”

Section: Fair Bmentioning

confidence: 99%

Recommendations from the Italian intersociety consensus on Perioperative Anesthesia Care in Thoracic surgery (PACTS) part 1: preadmission and preoperative care

et al. 2020

View full text Add to dashboard Cite

Introduction Anesthetic care in patients undergoing thoracic surgery presents specific challenges that necessitate standardized, multidisciplionary, and continuously updated guidelines for perioperative care. Methods A multidisciplinary expert group, the Perioperative Anesthesia in Thoracic Surgery (PACTS) group, comprising 24 members from 19 Italian centers, was established to develop recommendations for anesthesia practice in patients undergoing thoracic surgery (specifically lung resection for cancer). The project focused on preoperative patient assessment and preparation, intraoperative management (surgical and anesthesiologic care), and postoperative care and discharge. A series of clinical questions was developed, and PubMed and Embase literature searches were performed to inform discussions around these areas, leading to the development of 69 recommendations. The quality of evidence and strength of recommendations were graded using the United States Preventative Services Task Force criteria. Results Recommendations for preoperative care focus on risk assessment, patient preparation (prehabilitation), and the choice of procedure (open thoracotomy vs. video-assisted thoracic surgery). Conclusions These recommendations should help pulmonologists to improve preoperative management in thoracic surgery patients. Further refinement of the recommendations can be anticipated as the literature continues to evolve.

show abstract

“…Kitamura and colleagues [17] reported a large-scale multiinstitutional cohort of patients with lung cancer and coronary artery disease undergoing major lung resection. In this series, 564 of 1,254 patients (45.0%) received preoperative heparinization after discontinuation of antithrombotic agents.…”

Section: Commentmentioning

confidence: 99%

Impact of Preoperative Ultrasonography Screening for Carotid Artery Stenosis in Lung Cancer Patients

Fukushima

Takeo

Yamazaki

et al. 2018

The Annals of Thoracic Surgery

View full text Add to dashboard Cite

Feasibility of Pulmonary Resection for Lung Cancer in Patients With Coronary Artery Disease or Atrial Fibrillation

Abstract: Major lung resection for lung cancer in patients with coronary artery disease is feasible. Our study suggests that discontinuation of antiplatelet therapy may not increase postoperative complications in patients with coronary artery disease.

Cited by 6 publications

References 26 publications

Recommendations for perioperative management of lung cancer patients with comorbidities

Recommendations for perioperative management of lung cancer patients with comorbidities

Recommendations from the Italian intersociety consensus on Perioperative Anesthesia Care in Thoracic surgery (PACTS) part 1: preadmission and preoperative care

Impact of Preoperative Ultrasonography Screening for Carotid Artery Stenosis in Lung Cancer Patients

Contact Info

Product

Resources

About